Pulmonary arterial hypertension in critically ill elderly patients
- PMID: 28367167
- PMCID: PMC5368323
- DOI: 10.12669/pjms.331.10913
Pulmonary arterial hypertension in critically ill elderly patients
Abstract
Objective: To assess the incidence, possible risk factors and prognosis of pulmonary arterial hypertension (PAH) in critically ill elderly patients.
Methods: We selected 122 cases admitted to the ICU, ages 60-93 years old. An echocardiography examination was performed within four days after admission to the ICU. PAH is usually suspected if the patient's pulmonary artery systolic pressure ≥ 40 mmHg. We collected echocardiography data, relevant clinical data and routine laboratory data; we then used a statistical method to analyze the risk factors for PAH in critically ill elderly patients and examined its impact on the prognosis.
Results: Total 51 patients were diagnosed with PAH. The prevalence of critically ill elderly patients with PAH was 41.8%. The ANOVA analysis showed that if patients had COPD (P = 0.031) and/or respiratory failure (P = 0.021), they were more prone to PAH. An enlarged left atrium (P = 0.038) and/or right ventricle (P = 0.029), a declining left ventricle fractional shortening rate (P = 0.038), and an elevated amount of the brain natriuretic peptides (P = 0.046) were all associated with the occurrence of PAH. Multivariate regression analysis showed that the left atrial diameter (P = 0.045) was the risk factor in critically ill elderly patients with PAH. The 30-day mortality rate was 33.3% for elderly patients with PAH, which is statistically significant (P = 0.035) when compared with the mortality rate of patients with normal pulmonary artery pressure. Our multivariate regression analysis also showed that, for critically ill elderly patients admitted in the ICU, PAH (P = 0.039) is risk factor for increased mortality.
Conclusions: A higher incidence of PAH occurs in critically ill elderly patients. PAH is more likely to occur in patients with an enlarged left atrium, and these problems adversely impact the prognosis.
Keywords: Critically ill patients; Pulmonary arterial hypertension; Risk factors; The elderly.
Conflict of interest statement
Declaration of conflict of interest: None.
Similar articles
-
[Experts consensus on the management of the right heart function in critically ill patients].Zhonghua Nei Ke Za Zhi. 2017 Dec 1;56(12):962-973. doi: 10.3760/cma.j.issn.0578-1426.2017.12.017. Zhonghua Nei Ke Za Zhi. 2017. PMID: 29202543 Chinese.
-
[Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Dec 24;46(12):965-971. doi: 10.3760/cma.j.issn.0253-3758.2018.12.007. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 30572401 Chinese.
-
[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32370483 Chinese.
-
Association between right atrial area measured by echocardiography and prognosis among pulmonary arterial hypertension: a systematic review and meta-analysis.BMJ Open. 2020 Sep 22;10(9):e031316. doi: 10.1136/bmjopen-2019-031316. BMJ Open. 2020. PMID: 32963060 Free PMC article.
-
Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.Pharmacotherapy. 2010 Jul;30(7):728-40. doi: 10.1592/phco.30.7.728. Pharmacotherapy. 2010. PMID: 20575636 Review.
Cited by
-
Pulmonary Arterial Hypertension in the Elderly: Peculiar Features and Challenges for a Proper Phenotyping Approach.J Cardiovasc Dev Dis. 2023 Sep 18;10(9):401. doi: 10.3390/jcdd10090401. J Cardiovasc Dev Dis. 2023. PMID: 37754830 Free PMC article. Review.
-
Pulmonary Arterial Hypertension and Left Heart Disease Phenotype: A Challenging Crossroad.Cardiol Res. 2025 Jun 16;16(4):306-311. doi: 10.14740/cr2067. eCollection 2025 Aug. Cardiol Res. 2025. PMID: 40809733 Free PMC article. Review.
References
-
- Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S3–9. doi:10.1016/j.jacc.2009.04.009. - PubMed
-
- Zhicheng J, Xiqi X. The road to treat pulmonary hypertension, hard and promising. Chin J Intern Med. 2013;52(8):628–630. doi:10.3760/cma.j.issn.0578-1426.2013.08.002.
-
- McArdle JR, Trow TK, Lerz K. Pulmonary hypertension in older adults. Clin Chest Med. 2007;28(4):717–733. doi:10.1016/j.ccm.2007.08.006. - PubMed
-
- Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S55–66. doi:10.1016/j.jacc.2009.04.011. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources